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Reporting Checklist for Nature Neuroscience
This checklist is used to ensure good reporting standards and to improve the reproducibility of published results. For more information, please  
read Reporting Life Sciences Research. 
? ?
Please note that in the event of publication, it is mandatory that authors include all relevant methodological and statistical information in the 
manuscript. 
 Statistics reporting, by figure
?  Please specify the following information for each panel reporting quantitative data, and where each item is reported (section, e.g. Results, & 
paragraph number). ?
??
??Each figure legend should ideally contain an exact sample size (n) for each experimental group/condition, where n is an exact number and not a  ?
   range, a clear definition of how n is defined (for example x cells from x slices from x animals from x litters, collected over x days), a description of  
   the statistical test used, the results of the tests, any descriptive statistics and clearly defined error bars if applicable. ? 
??
?  For any experiments using custom statistics, please indicate the test used and stats obtained for each experiment.??
??
?  Each figure legend should include a statement of how many times the experiment shown was replicated in the lab; the details of sample ?
   collection should be sufficiently clear so that the replicability of the experiment is obvious to the reader.? 
??
?  For experiments reported in the text but not in the figures, please use the paragraph number instead of the figure number.?
 
Note: Mean and standard deviation are not appropriate on small samples, and plotting independent data points is usually more informative.  
When technical replicates are reported, error and significance measures reflect the experimental variability and not the variability of the biological 
process; it is misleading not to state this clearly.  
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 Representative figures
1.    Are any representative images shown (including Western blots and 
immunohistochemistry/staining) in the paper?  
If so, what figure(s)?
A representative cell response along with action potential 
waveforms is shown in Fig. 1.
2.    For each representative image, is there a clear statement of               
how many times this experiment was successfully repeated and a 
discussion of any limitations in repeatability?  
If so, where is this reported (section, paragraph #)?
We report the total number of neurons we recorded as well as the 
fraction of neurons that were significantly modulated by person 
identity or gaze direction.
 Statistics and general methods
1.    Is there a justification of the sample size? 
If so, how was it justified?  
Where (section, paragraph #)?  
       Even if no sample size calculation was performed, authors should 
report why the sample size is adequate to measure their effect size. 
The number of subjects, experimental sessions, and recorded units 
already exceeds that of most studies reported in the field of human 
single unit recordings by far. 
We find clear effects of person identity, but not of gaze direction, 
so the sample size is clearly sufficient for comparing these two 
factors. We also report a significant difference in effects sizes for 
these two factors.
2.   Are statistical tests justified as appropriate for every figure?  
Where (section, paragraph #)?
Yes, they are described and justified in the sections 'Statistical 
analysis' and 'Representational Similarity Analysis' in the 
Supplemental Online Material (SOM).
a.    If there is a section summarizing the statistical methods in 
the methods, is the statistical test for each experiment 
clearly defined? 
Yes. See sections 'Statistical analysis' and 'Representational 
Similarity Analysis'.
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b.   Do the data meet the assumptions of the specific statistical 
test you chose (e.g. normality for a parametric test)?  
Where is this described (section, paragraph #)?
Whenever possible, we used nonparametric tests or even 
permutation tests. See sections 'Statistical analysis' and 
'Representational Similarity Analysis'.
c.    Is there any estimate of variance within each group of  data?  
Is the variance similar between groups that are being 
statistically compared?  
Where is this described (section, paragraph #)?
Whenever possible we used nonparametric tests or permutation 
tests that make no assumptions about the variance of the data 
groups.
d.    Are tests specified as one- or two-sided? All tests were two-sided as specified in the SOM.
e.    Are there adjustments for multiple comparisons?  Yes. By using an omnibus test (2-way ANOVA) and subsequent 
binomial tests.
3.    Are criteria for excluding data points reported?  
Was this criterion established prior to data collection?  
Where is this described (section, paragraph #)?
No data were excluded.
4.    Define the method of randomization used to assign subjects (or 
samples) to the experimental groups and to collect and process data.   
If no randomization was used, state so.  
Where does this appear (section, paragraph #)?
No randomization was used except for the permutation test 
described in the section 'Representational Similarity Analysis' in the 
Supplemental Online Material.
5.    Is a statement of the extent to which investigator knew the group 
allocation during the experiment and in assessing outcome included?   
If no blinding was done, state so.  
Where (section, paragraph #)?
n/a
6.    For experiments in live vertebrates, is a statement of compliance with 
ethical guidelines/regulations included?  
Where (section, paragraph #)?
The Medical Institutional Review Board at the University of Bonn 
approved the protocol. This is stated in the first paragraph of the 
Supplemental Online Material.
7.    Is the species of the animals used reported?  
Where (section, paragraph #)?
n/a
8.    Is the strain of the animals (including background strains of KO/
transgenic animals used) reported?  
Where (section, paragraph #)?
n/a
9.    Is the sex of the animals/subjects used reported?  
Where (section, paragraph #)?
Sex of the human subjects is reported in the first paragraph of the 
Supplemental Online Material.
10.  Is the age of the animals/subjects reported?  
Where (section, paragraph #)?
Age of the human subjects is reported in the first paragraph of the 
Supplemental Online Material.
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11.  For animals housed in a vivarium, is the light/dark cycle reported? 
Where (section, paragraph #)?
n/a
12.  For animals housed in a vivarium, is the housing group (i.e. number of 
animals per cage) reported? 
Where (section, paragraph #)?
n/a
13.  For behavioral experiments, is the time of day reported (e.g. light or 
dark cycle)?  
Where (section, paragraph #)?
All experiments were performed during the day.
14.  Is the previous history of the animals/subjects (e.g. prior drug 
administration, surgery, behavioral testing) reported? 
Where (section, paragraph #)? 
 
Yes. They all have epilepsy.
a.    If multiple behavioral tests were conducted in the same 
group of animals, is this reported? 
Where (section, paragraph #)?
n/a
15.  If any animals/subjects were excluded from analysis, is this reported?  
Where (section, paragraph #)?
No subject was excluded.
a.    How were the criteria for exclusion defined?  
Where is this described (section, paragraph #)?
n/a
b.    Specify reasons for any discrepancy between the number of 
animals at the beginning and end of the study.   
Where is this described (section, paragraph #)?
n/a
 Reagents
1.    Have antibodies been validated for use in the system under study 
(assay and species)? 
a.    Is antibody catalog number given?  
Where does this appear (section, paragraph #)?
b.    Where were the validation data reported (citation, 
supplementary information, Antibodypedia)?  
Where does this appear (section, paragraph #)?
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2.    If cell lines were used to reflect the properties of a particular tissue or 
disease state, is their source identified?  
Where (section, paragraph #)?
a.    Were they recently authenticated?  
Where is this information reported (section, paragraph #)?
 Data deposition
Data deposition in a public repository is mandatory for: 
     a. Protein, DNA and RNA sequences 
     b. Macromolecular structures 
     c. Crystallographic data for small molecules 
     d. Microarray data 
Deposition is strongly recommended for many other datasets for which structured public repositories exist; more details on our data policy are 
available here. We encourage the provision of other source data in supplementary information or in unstructured repositories such as Figshare 
and Dryad.
1.    Are accession codes for deposit dates provided? 
Where (section, paragraph #)?
We'd be happy to share the data. Due to the high sampling rates, 
however, the size of the total data set is in the order of 1 Terabyte 
so it cannot be distributed over the web.
 Computer code/software
Any custom algorithm/software that is central to the methods must be supplied by the authors in a usable and readable form for readers at the 
time of publication. However, referees may ask for this information at any time during the review process.
 1.   Identify all custom software or scripts that were required to conduct 
the study and where in the procedures each was used.
Matlab was used to perform the statistical analyses and for 
generating the figures.
2.   Is computer source code/software provided with the paper or 
deposited in a public repository? Indicate in what form this is provided 
or how it can be obtained.
For extraction and sorting of action potentials (spikes), we used 
Waveclus, a Matlab-based software freely available on the web.
 Human subjects
1.    Which IRB approved the protocol?  
Where is this stated (section, paragraph #)?
The Medical Institutional Review Board at the University of Bonn 
approved the protocol. This is stated in the first paragraph of the 
Supplemental Online Material.
2.    Is demographic information on all subjects provided?  
Where (section, paragraph #)?
Number, age and sex of subjects are stated in the first paragraph of 
the Supplemental Online Material.
3.    Is the number of human subjects, their age and sex clearly defined?  
Where (section, paragraph #)?
Number, age and sex of subjects are stated in the first paragraph of 
the Supplemental Online Material.
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4.    Are the inclusion and exclusion criteria (if any) clearly specified?  
Where (section, paragraph #)? 
n/a. No data was excluded.
5.    How well were the groups matched?  
Where is this information described (section, paragraph #)?
n/a. No group comparison.
6.    Is a statement included confirming that informed consent was 
obtained from all subjects? 
Where (section, paragraph #)?
Informed written consent was obtained from each subject. This is 
stated in the first paragraph of the Supplemental Online Material.
7.    For publication of patient photos, is a statement included confirming 
that consent to publish was obtained? 
Where (section, paragraph #)?
Yes. This statement is included in the figure caption of 
Supplemental Figure 2.
 fMRI studies
For papers reporting functional imaging (fMRI) results please ensure that these minimal reporting guidelines are met and that all this 
information is clearly provided in the methods:
1.    Were any subjects scanned but then rejected for the analysis after the 
data was collected? 
a.    If yes, is the number rejected and reasons for rejection 
described?  
Where (section, paragraph #)?
2.    Is the number of blocks, trials or experimental units per session and/
or subjects specified?  
Where (section, paragraph #)?
3.    Is the length of each trial and interval between trials specified? 
4.    Is a blocked, event-related, or mixed design being used? If applicable, 
please specify the block length or how the event-related or mixed 
design was optimized.
5.    Is the task design clearly described?  
Where (section, paragraph #)?
6.    How was behavioral performance measured?
7.    Is an ANOVA or factorial design being used?
8.    For data acquisition, is a whole brain scan used?  
If not, state area of acquisition. 
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a.    How was this region determined?
9.  Is the field strength (in Tesla) of the MRI system stated? 
a.    Is the pulse sequence type (gradient/spin echo, EPI/spiral) 
stated?
b.    Are the field-of-view, matrix size, slice thickness, and TE/TR/
flip angle clearly stated?
10.  Are the software and specific parameters (model/functions, 
smoothing kernel size if applicable, etc.) used for data processing and 
pre-processing clearly stated?
11.  Is the coordinate space for the anatomical/functional imaging data 
clearly defined as subject/native space or standardized stereotaxic 
space, e.g., original Talairach, MNI305, ICBM152, etc? Where (section, 
paragraph #)?
12.  If there was data normalization/standardization to a specific space 
template, are the type of transformation (linear vs. nonlinear) used 
and image types being transformed clearly described? Where (section, 
paragraph #)?
13.  How were anatomical locations determined, e.g., via an automated 
labeling algorithm (AAL), standardized coordinate database (Talairach 
daemon), probabilistic atlases, etc.?
14.  Were any additional regressors (behavioral covariates, motion etc) 
used?
15.  Is the contrast construction clearly defined? 
16.  Is a mixed/random effects or fixed inference used? 
a.    If fixed effects inference used, is this justified?
17.  Were repeated measures used (multiple measurements per subject)? 
a.    If so, are the method to account for within subject 
correlation and the assumptions made about variance 
clearly stated?
18.  If the threshold used for inference and visualization in figures varies, is 
this clearly stated? 
19.  Are statistical inferences corrected for multiple comparisons? 
a.    If not, is this labeled as uncorrected?
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20.  Are the results based on an ROI (region of interest) analysis? 
a.    If so, is the rationale clearly described? 
b.    How were the ROI’s defined (functional vs anatomical 
localization)? 
21.  Is there correction for multiple comparisons within each voxel? 
22.  For cluster-wise significance, is the cluster-defining threshold and the 
corrected significance level defined? 
 Additional comments
     Additional Comments
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